Ordinance
on Clinical Trials
with the exception of
Clinical Trials of Medical Devices1
(Clinical Trials Ordinance, ClinO)

of 20 September 2013 (Status as of 26 May 2022)

1 Amended by Annex 2 No 2 of the O of 1 July 2020 on Clinical Trials with Medical Devices, in force since 26 May 2021 (AS 2020 3033).


Open article in different language:  DE  |  FR  |  IT
Art. 24 Application

1 The in­vest­ig­at­or shall sub­mit to the re­spons­ible eth­ics com­mit­tee the ap­plic­a­tion doc­u­ments spe­cified in An­nex 3 for re­view.

2 The eth­ics com­mit­tee may re­quest ad­di­tion­al in­form­a­tion.

3 The spon­sor may sub­mit the ap­plic­a­tion in­stead of the in­vest­ig­at­or. In this case, the spon­sor as­sumes the ob­lig­a­tions of the in­vest­ig­at­or as spe­cified in Art­icles 28 and 29 and also the no­ti­fic­a­tion and re­port­ing ob­lig­a­tions vis-à-vis the re­spons­ible eth­ics com­mit­tee. The ap­plic­a­tion doc­u­ments must be co-signed by the in­vest­ig­at­or.

Previous article Show article in the law Next article

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Gesetzeskürzel Name
DE FR IT EN
DE FR IT EN
Laden